(S)-N-Fmoc-3-amino-4-(4-chlorophenyl)butyric acid is a non-natural, chiral amino acid derivative. Its structure features an Fmoc (9-fluorenylmethoxycarbonyl) protecting group on the amine, a carboxylic acid group, and a 4-chlorophenyl side chain. The presence of the Fmoc group is a hallmark of solid-phase peptide synthesis (SPPS) methodology. This compound serves as a crucial building block, or unnatural amino acid, in the synthesis of peptides and peptidomimetics. The Fmoc group allows for its selective incorporation into peptide chains using standard Fmoc-SPPS protocols, while the chlorophenyl side chain introduces specific hydrophobic and steric properties. Such modified amino acids are extensively used in medicinal chemistry research to modulate the biological activity, stability, and pharmacokinetic profiles of therapeutic peptide candidates. Its primary application lies in the development of novel peptide-based drugs and bioactive probes. The chlorinated aromatic ring can be involved in π-π stacking interactions or serve as a handle for further chemical modifications, making it a valuable tool for exploring structure-activity relationships in drug discovery programs targeting various diseases.